2021
DOI: 10.1111/bjh.17848
|View full text |Cite
|
Sign up to set email alerts
|

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement

Abstract: We assessed the diagnostic performances of erythropoietin and JAK2 mutations in 1,090 patients with suspected polycythemia who were referred for red cell mass (RCM) measurement. In patients with a high haematocrit and/or haemoglobin level, a low erythropoietin level (<=3Á3 mUI/ml) and JAK2 mutation showed comparable positive predictive value (PPV) for true polycythemia (RCM>=125%), 92Á1% and 90% respectively. A very-low erythropoietin level (<=1Á99 mUI/ml) had a PPV of 100% for polycythemia vera (PV) diagnosis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 14 publications
(40 reference statements)
0
3
0
Order By: Relevance
“…EPO was also significantly lower in the PV group ( p < 0.001, Figure 3H; Table S1), and all but two patients in the PV group exhibited EPO levels below the lower range of normal (<4.2 IU/L). Notably, 18 (40.8%) of the 44 NNE patients with available EPO data showed low EPO levels, which is a trait that has not been previously reported in NNE 15,16 …”
Section: Resultsmentioning
confidence: 63%
See 1 more Smart Citation
“…EPO was also significantly lower in the PV group ( p < 0.001, Figure 3H; Table S1), and all but two patients in the PV group exhibited EPO levels below the lower range of normal (<4.2 IU/L). Notably, 18 (40.8%) of the 44 NNE patients with available EPO data showed low EPO levels, which is a trait that has not been previously reported in NNE 15,16 …”
Section: Resultsmentioning
confidence: 63%
“…Notably, 18 (40.8%) of the 44 NNE patients with available EPO data showed low EPO levels, which is a trait that has not been previously reported in NNE. 15 , 16 …”
Section: Resultsmentioning
confidence: 99%
“… 8 Further, higher JAK2 V617F VAF is associated with increased red cell mass, decreased serum iron, decreased transferrin saturation, and lower serum erythropoietin ( Table 1 ). 8 , 37 , 38 , 42 Excess HIF may be the basis of the reduced hepcidin, increased erythroferrone, and altered iron metabolism observed in patients with PV, although additional mechanisms may be at play. 43 PV neutrophils have increased HIF-mediated gene expression as well as increased expression of tissue factor, F3 , the primary initiator of the extrinsic pathway of coagulation, which again correlate with JAK2 V617F VAF ( Figure 1 B) 32 , 43 , 44 , 45 , 46 Further, clonal neutrophils in PV exhibited enhanced ability to release extracellular traps, activate integrin signaling, and enhance adhesion.…”
Section: Jak2 V617f Vaf In Hsc and Terminally Dif...mentioning
confidence: 99%